PMS2 and breast carcinoma: We studied 31 cases of locally advanced breast carcinoma (LABC) for correlation between MMR dysfunction, clinicopathological parameters and response to chemotherapy using immunohistochemistry for four MMR protein products -MLH1, MSH2, MSH6 and PMS2, before and after NACT.